Faith B Dickerson
Overview
Explore the profile of Faith B Dickerson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
3019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daumit G, Evins A, Cather C, Dalcin A, Dickerson F, Miller 3rd E, et al.
JAMA Psychiatry
. 2023 Jun;
80(9):895-904.
PMID: 37378972
Importance: Tobacco smoking drives markedly elevated cardiovascular disease risk and preventable death in persons with serious mental illness, and these risks are compounded by the high prevalence of overweight/obesity that...
2.
Dickerson F, Severance E, Yolken R
Curr Top Behav Neurosci
. 2022 Aug;
61:265-278.
PMID: 35947355
Background: The pandemic caused by severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) has highlighted the importance of coronaviruses in human health. Several seasonal, non-SARS Coronaviruses are endemic in most areas of the...
3.
Jerome G, Fink T, Brady T, Young D, Dickerson F, Goldsholl S, et al.
Int J Environ Res Public Health
. 2022 Feb;
19(4).
PMID: 35206449
Youth with mental illness have higher levels of obesity than children in the general population. Both regular physical activity and limited screen time have been recommended to reduce and prevent...
4.
Huang W, Chang C, Stuart E, Daumit G, Wang N, McGinty E, et al.
Implement Res Pract
. 2021 Jul;
2.
PMID: 34308355
Background: Implementation researchers have sought ways to use simulations to support the core components of implementation, which typically include assessing the need for change, designing implementation strategies, executing the strategies,...
5.
Daumit G, Dalcin A, Dickerson F, Miller E, Evins A, Cather C, et al.
JAMA Netw Open
. 2020 Jun;
3(6):e207247.
PMID: 32530472
Importance: Persons with serious mental illness have a cardiovascular disease mortality rate more than twice that of the overall population. Meaningful cardiovascular risk reduction requires targeted efforts in this population,...
6.
Dalcin A, Jerome G, Appel L, Dickerson F, Wang N, Miller E, et al.
Front Psychiatry
. 2019 Feb;
9:786.
PMID: 30800079
Persons with serious mental illness (SMI) comprise a high-risk group for cardiovascular disease (CVD)-related mortality with rates at least twice those of the overall US. Potentially modifiable CVD risk behaviors...
7.
Breier A, Buchanan R, DSouza D, Nuechterlein K, Marder S, Dunn W, et al.
Schizophr Res
. 2018 Nov;
206:291-299.
PMID: 30478008
Background: Several studies have implicated herpes simplex virus-type 1 (HSV-1) in the pathophysiology of schizophrenia. A recent trial demonstrated that the anti-viral medication valacylovir, which prevents replication of activated HSV-1,...
8.
9.
Kelly D, Powell M, Wehring H, Sayer M, Kearns A, Hackman A, et al.
J Clin Psychopharmacol
. 2018 Jun;
38(4):317-326.
PMID: 29912799
Purpose/background: Prolactin-related adverse effects contribute to nonadherence and adverse health consequences, particularly in women with severe mental illness. Treating these adverse effects may improve treatment acceptability, adherence, and long-term outcomes....
10.
Severance E, Dickerson F, Yolken R
Pharmacol Ther
. 2018 May;
189:184-198.
PMID: 29742478
Typical and atypical antipsychotics are the first-line treatments for schizophrenia, but these classes of drugs are not universally effective, and they can have serious side effects that impact compliance. Antipsychotic...